News

Fierce Biotech4h
Korean CRO CorestemChemon inks collaboration to expand into organoids and transcriptomics
Korean preclinical CRO CorestemChemon is expanding its offerings through a partnership with ATG Lifetech, with the goal of ...
Fierce Biotech7h
FDA amplifies neurosurgery kit recall efforts at Medline, Integra
The FDA is amplifying an effort underway at the medical device distributor Medline, which aims to correct certain ...
Fierce Biotech15h
Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio and boosting its pipeline beyond mRNA
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...
Fierce Biotech10h
Scancell picks winner from phase 2 cancer vaccine face off, choosing next-gen prospect for pivotal trial
Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...
Fierce Biotech10h
Replimune's shares crater as FDA rejects melanoma drug
The FDA has rejected Replimune’s request for approval of RP1, adding the melanoma drug candidate to the list of assets to ...
Fierce Biotech6h
Hyperfine begins rolling out its next-gen MRI scanner-on-wheels
The portable MRI manufacturer Hyperfine has begun rolling out the next generation of its artificial intelligence-equipped scanner-on-wheels, following an FDA green light last month.  | The Fierce ...